Healthcare

Longevity medicine is changing physician-patient dynamics. Download our framework for healthcare professionals navigating new patient expectations and structural barriers.

How Chinese Biopharma Innovation is Forging the Future of Global Oncology Deal Making.

The cancer treatment landscape continues to evolve at speed. For all those working in oncology today, being able to adeptly respond to these shifts is imperative for brand success.

Early-stage immunotherapy: turn the perioperative "black box" into a clear path to ROI.

Turn longevity from trend to strategy: where should pharma play - and how to win?

Despite media discussions around the drugs, only around a third across 30 countries have heard about the drugs, with a lot of the discourse taking place via social media according to the Ipsos Health Service Report.

Built on the foundation of Ipsos’ gold-standard Global Healthcare Monitors, the Ipsos Rx Insight Store offers standardised reports and dashboards that empower biopharma companies to make rapid, informed decisions for brand success.

How our changing world is impacting our cells, and what it means for all of us.

What are the promises and limitations of different therapeutic modalities in solid tumors? As we approach the mid-year point, we reflect on the advancements in oncology in recent years.